179 related articles for article (PubMed ID: 37835436)
21. Crohn's disease-like reaction predicts favorable prognosis in colitis-associated colorectal cancer.
Lewis B; Lin J; Wu X; Xie H; Shen B; Lai K; Manilich E; Liu X
Inflamm Bowel Dis; 2013 Sep; 19(10):2190-8. PubMed ID: 23917251
[TBL] [Abstract][Full Text] [Related]
22. Mast cell-T cell axis alters development of colitis-dependent and colitis-independent colorectal tumours: potential for therapeutically targeting via mast cell inhibition.
Sakita JY; Elias-Oliveira J; Carlos D; de Souza Santos E; Almeida LY; Malta TM; Brunaldi MO; Albuquerque S; Araújo Silva CL; Andrade MV; Bonato VLD; Garcia SB; Cunha FQ; Cebinelli GCM; Martins RB; Matthews J; Colli L; Martin FL; Uyemura SA; Kannen V
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36220303
[TBL] [Abstract][Full Text] [Related]
23. Colitis-Associated Colorectal Cancer Survival is Comparable to Sporadic Cases after Surgery: a Matched-Pair Analysis.
Raje P; Sonal S; Qwaider YZ; Sell NM; Stafford CE; Boudreau C; Schneider D; Ike A; Kunitake H; Berger DL; Ricciardi R; Bordeianou LG; Cauley CE; Lee GC; Goldstone RN
J Gastrointest Surg; 2023 Jul; 27(7):1423-1428. PubMed ID: 37165158
[TBL] [Abstract][Full Text] [Related]
24. Tumor Infiltrating Regulatory T Cells in Sporadic and Colitis-Associated Colorectal Cancer: The Red Little Riding Hood and the Wolf.
Fantini MC; Favale A; Onali S; Facciotti F
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937953
[TBL] [Abstract][Full Text] [Related]
25. The correlation of microsatellite instability and tumor-infiltrating lymphocytes in hereditary non-polyposis colorectal cancer (HNPCC) and sporadic colorectal cancers: the significance of different types of lymphocyte infiltration.
Takemoto N; Konishi F; Yamashita K; Kojima M; Furukawa T; Miyakura Y; Shitoh K; Nagai H
Jpn J Clin Oncol; 2004 Feb; 34(2):90-8. PubMed ID: 15067103
[TBL] [Abstract][Full Text] [Related]
26. Status of Gene Methylation and Polymorphism in Different Courses of Ulcerative Colitis and Their Comparison with Sporadic Colorectal Cancer.
Liu C; Yuan ZY; Yuan H; Wu KX; Cao B; Ren KY; Cui MJ; Liu JH; Chen HX; Pang YW
Inflamm Bowel Dis; 2021 Mar; 27(4):522-529. PubMed ID: 32793962
[TBL] [Abstract][Full Text] [Related]
27. Molecular Pathogenesis of Colitis-associated Colorectal Cancer: Immunity, Genetics, and Intestinal Microecology.
Yin Y; Wan J; Yu J; Wu K
Inflamm Bowel Dis; 2023 Oct; 29(10):1648-1657. PubMed ID: 37202830
[TBL] [Abstract][Full Text] [Related]
28. Update and latest advances in mechanisms and management of colitis-associated colorectal cancer.
Dan WY; Zhou GZ; Peng LH; Pan F
World J Gastrointest Oncol; 2023 Aug; 15(8):1317-1331. PubMed ID: 37663937
[TBL] [Abstract][Full Text] [Related]
29. The in situ local immune response, tumour senescence and proliferation in colorectal cancer.
Roxburgh CS; Richards CH; Macdonald AI; Powell AG; McGlynn LM; McMillan DC; Horgan PG; Edwards J; Shiels PG
Br J Cancer; 2013 Oct; 109(8):2207-16. PubMed ID: 24022192
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms in colitis-associated colorectal cancer.
Zhou RW; Harpaz N; Itzkowitz SH; Parsons RE
Oncogenesis; 2023 Oct; 12(1):48. PubMed ID: 37884500
[TBL] [Abstract][Full Text] [Related]
31. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility.
Uronis JM; Mühlbauer M; Herfarth HH; Rubinas TC; Jones GS; Jobin C
PLoS One; 2009 Jun; 4(6):e6026. PubMed ID: 19551144
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic value of inflammatory cell infiltrates, tumor stroma percentage and disease-free survival in patients with colorectal cancer.
Jakubowska K; Kisielewski W; Kańczuga-Koda L; Koda M; Famulski W
Oncol Lett; 2017 Sep; 14(3):3869-3877. PubMed ID: 28927159
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of phosphorylated sphingosine kinase 1 expression in colitis-associated cancer.
Yuza K; Nagahashi M; Shimada Y; Nakano M; Tajima Y; Kameyama H; Nakajima M; Takabe K; Wakai T
J Surg Res; 2018 Nov; 231():323-330. PubMed ID: 30278948
[TBL] [Abstract][Full Text] [Related]
34. RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression.
Liu ZY; Zheng M; Li YM; Fan XY; Wang JC; Li ZC; Yang HJ; Yu JM; Cui J; Jiang JL; Tang J; Chen ZN
Theranostics; 2019; 9(12):3659-3673. PubMed ID: 31281505
[No Abstract] [Full Text] [Related]
35. Histomorphological features and prognosis of colitis-associated colorectal cancer in patients with primary sclerosing cholangitis.
Liu G; Lin J; Xie H; Shen B; Stocchi L; Liu X
Scand J Gastroenterol; 2015; 50(11):1389-96. PubMed ID: 26061393
[TBL] [Abstract][Full Text] [Related]
36. The Different Immune Profiles of Normal Colonic Mucosa in Cancer-Free Lynch Syndrome Carriers and Lynch Syndrome Colorectal Cancer Patients.
Bohaumilitzky L; Kluck K; Hüneburg R; Gallon R; Nattermann J; Kirchner M; Kristiansen G; Hommerding O; Pfuderer PL; Wagner L; Echterdiek F; Kösegi S; Müller N; Fischer K; Nelius N; Hartog B; Borthwick G; Busch E; Haag GM; Bläker H; Möslein G; von Knebel Doeberitz M; Seppälä TT; Ahtiainen M; Mecklin JP; Bishop DT; Burn J; Stenzinger A; Budczies J; Kloor M; Ahadova A
Gastroenterology; 2022 Mar; 162(3):907-919.e10. PubMed ID: 34863788
[TBL] [Abstract][Full Text] [Related]
37. Identification of Novel Core Genes Involved in Malignant Transformation of Inflamed Colon Tissue Using a Computational Biology Approach and Verification in Murine Models.
Markov AV; Savin IA; Zenkova MA; Sen'kova AV
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901742
[TBL] [Abstract][Full Text] [Related]
38.
Silveira DSC; Veronez LC; Lopes-Júnior LC; Anatriello E; Brunaldi MO; Pereira-da-Silva G
World J Gastroenterol; 2020 Nov; 26(43):6782-6794. PubMed ID: 33268961
[TBL] [Abstract][Full Text] [Related]
39. Loss of survival advantage for deficient mismatch repair in patients with advanced colorectal cancer may be caused by changes in prognostic value of CD8+T cell.
Wang B; Li F; Guo L; Lu S; Ma J; Ma Y; Meng Y; Wang J; Zhou X; Fu W
World J Surg Oncol; 2020 Aug; 18(1):196. PubMed ID: 32767974
[TBL] [Abstract][Full Text] [Related]
40. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
